02 July 2026

Awareness Circular – Warning about using falsified lots of medical products JAKAVI (ruxolitinib)

Reference: CIR-2026-00000096

Awareness Circular – Warning about using falsified lots of medical products JAKAVI (ruxolitinib)

 

To all Health facilities and healthcare practitioners in Dubai's private health sector

Referring to the above subject, DHA notifies all health facilities regarding the circulars issued by the Emirates Drug Establishment for perusal and adherence to what is stated.

 

Circular No. (28/2026): Awareness Circular – Warning about using falsified lots of medical products JAKAVI (ruxolitinib).

 

Thanks in advance for your good co-operation

 

 Drug Control Section

Health Regulation

Supporting Documents:

Awareness Circular - Warning about using falsified lots of medical products JAKAVI (ruxolitinib).pdf:

View Document